Bioentrepreneur Contents: June 2015

If you are unable to see the message below, click here to view.

Latest Data Page

Research biotech patenting 2014

SciCafé

Startups on the menu: Atreca

Trade Secrets Blog

The Bioentrepreneur blog, Trade Secrets, boasts contributors from around the globe, providing regular insight and commentary from those helping build the world's biotechnology sectors.

Podcast

The new episode of Nature Biotechnology's First Rounders podcast features Colin Goddard, who is the former CEO of OSI Pharmaceuticals, and current chairman and CEO of Coferon. His conversation with Nature Biotechnology details the history behind OSI's blockbuster drug Tarceva (erlotinib), the benefits of having a British accent in the United States and how to survive a hostile takeover.

View more articles

Advertisement

Biopharma Dealmakers  A supplement to Nature Biotechnology and Nature Reviews Drug Discovery  The March 2015 issue of Biopharma Dealmakers showcases companies with partnering opportunities. Find out how you can collaborate with Mucosis, Immunomic Therapeutics, and ABIVAX.

Advertisement

More from Biopharma Dealmakers  The March 2015 issue also features partnering opportunities with ILiAD Biotechnologies and Replikins.   Sign up for our e-alerts to access the cutting edge editorials on burgeoning therapeutic areas and the latest updates on the partnering landscape for free.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston